Depression

Christine J. Choe; Graham J. Emslie; Taryn L. Mayes

doi:10.1016/j.chc.2012.07.002

Depression

Christine J. Choe, Graham J. Emslie, Taryn L. Mayes

Research output: Contribution to journal › Review article › peer-review

7 Scopus citations

Abstract

This article reviews the assessment and treatment for depression in children and adolescents, emphasizing the implementation of evidence-based treatments into clinical care. Past trials of antidepressant medications are reviewed, as well as the clinical use of antidepressants and pharmacologic strategies for refractory illness or in the context of comorbid conditions. Clinicians who treat youth now have a body of empiric research to help guide treatment decisions; however, personalized treatment based on associated symptoms, comorbid conditions, contextual factors, and psychiatric history is essential. Further research is needed in the pharmacologic treatment of depressed youth, including expanding the study of non-SSRI antidepressants, augmentation and adjunctive strategies, and treatment in patients with comorbid conditions.

Original language	English (US)
Pages (from-to)	807-829
Number of pages	23
Journal	Child and Adolescent Psychiatric Clinics of North America
Volume	21
Issue number	4
DOIs	https://doi.org/10.1016/j.chc.2012.07.002
State	Published - Oct 1 2012

Keywords

Antidepression treatment
Depression
MDD
Psychopharmacotherapy
Youth depression

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Psychiatry and Mental health

Access to Document

10.1016/j.chc.2012.07.002

Fingerprint Dive into the research topics of 'Depression'. Together they form a unique fingerprint.

Cite this

@article{ee0a1f71193742bcafce600133e6390c,

title = "Depression",

abstract = "This article reviews the assessment and treatment for depression in children and adolescents, emphasizing the implementation of evidence-based treatments into clinical care. Past trials of antidepressant medications are reviewed, as well as the clinical use of antidepressants and pharmacologic strategies for refractory illness or in the context of comorbid conditions. Clinicians who treat youth now have a body of empiric research to help guide treatment decisions; however, personalized treatment based on associated symptoms, comorbid conditions, contextual factors, and psychiatric history is essential. Further research is needed in the pharmacologic treatment of depressed youth, including expanding the study of non-SSRI antidepressants, augmentation and adjunctive strategies, and treatment in patients with comorbid conditions.",

keywords = "Antidepression treatment, Depression, MDD, Psychopharmacotherapy, Youth depression",

author = "Choe, {Christine J.} and Emslie, {Graham J.} and Mayes, {Taryn L.}",

year = "2012",

month = oct,

day = "1",

doi = "10.1016/j.chc.2012.07.002",

language = "English (US)",

volume = "21",

pages = "807--829",

journal = "Child and Adolescent Psychiatric Clinics of North America",

issn = "1056-4993",

publisher = "W.B. Saunders Ltd",

number = "4",

}

TY - JOUR

T1 - Depression

AU - Choe, Christine J.

AU - Emslie, Graham J.

AU - Mayes, Taryn L.

PY - 2012/10/1

Y1 - 2012/10/1

N2 - This article reviews the assessment and treatment for depression in children and adolescents, emphasizing the implementation of evidence-based treatments into clinical care. Past trials of antidepressant medications are reviewed, as well as the clinical use of antidepressants and pharmacologic strategies for refractory illness or in the context of comorbid conditions. Clinicians who treat youth now have a body of empiric research to help guide treatment decisions; however, personalized treatment based on associated symptoms, comorbid conditions, contextual factors, and psychiatric history is essential. Further research is needed in the pharmacologic treatment of depressed youth, including expanding the study of non-SSRI antidepressants, augmentation and adjunctive strategies, and treatment in patients with comorbid conditions.

AB - This article reviews the assessment and treatment for depression in children and adolescents, emphasizing the implementation of evidence-based treatments into clinical care. Past trials of antidepressant medications are reviewed, as well as the clinical use of antidepressants and pharmacologic strategies for refractory illness or in the context of comorbid conditions. Clinicians who treat youth now have a body of empiric research to help guide treatment decisions; however, personalized treatment based on associated symptoms, comorbid conditions, contextual factors, and psychiatric history is essential. Further research is needed in the pharmacologic treatment of depressed youth, including expanding the study of non-SSRI antidepressants, augmentation and adjunctive strategies, and treatment in patients with comorbid conditions.

KW - Antidepression treatment

KW - Depression

KW - MDD

KW - Psychopharmacotherapy

KW - Youth depression

UR - http://www.scopus.com/inward/record.url?scp=84867060982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867060982&partnerID=8YFLogxK

U2 - 10.1016/j.chc.2012.07.002

DO - 10.1016/j.chc.2012.07.002

M3 - Review article

C2 - 23040903

AN - SCOPUS:84867060982

VL - 21

SP - 807

EP - 829

JO - Child and Adolescent Psychiatric Clinics of North America

JF - Child and Adolescent Psychiatric Clinics of North America

SN - 1056-4993

IS - 4

ER -